Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$4.18 - $7.74 $923 - $1,710
-221 Reduced 1.85%
11,740 $67,000
Q1 2022

Apr 22, 2022

SELL
$7.12 - $11.06 $2,057 - $3,196
-289 Reduced 2.36%
11,961 $96,000
Q4 2021

Feb 14, 2022

SELL
$8.97 - $14.08 $14,683 - $23,048
-1,637 Reduced 11.79%
12,250 $142,000
Q3 2021

Nov 05, 2021

SELL
$10.25 - $15.21 $5,637 - $8,365
-550 Reduced 3.81%
13,887 $189,000
Q2 2021

Aug 16, 2021

SELL
$12.4 - $17.92 $12,238 - $17,687
-987 Reduced 6.4%
14,437 $216,000
Q1 2021

May 17, 2021

BUY
$13.9 - $22.0 $214,393 - $339,328
15,424 New
15,424 $270,000

Others Institutions Holding XGN

About EXAGEN INC.


  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $76.6M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.